A chemically inducible cucumber mosaic virus amplicon expression system for the production of recombinant proteins in plant-based systems.
Plant cell cultures and transgenic plants have been developing as a potential platform for production of recombinant proteins, particularly playing an increasingly important role in production of human therapeutics. However, efficient expression systems that can be tightly regulated are currently lacking for plant-based protein expression.
Researchers at University of California, Davis have developed a novel protein expression system, called Cucumber Mosaic Virus Inducible Viral Amplicon (CMViva), to inducibly and efficiently produce recombinant proteins in transgenic plant cell cultures. This novel protein expression system can produce recombinant proteins in plant-based systems using either transient expression in whole plants, plant tissues or plant cell cultures (using wild type, non-transgenic host tissues), stably transformed plant cell cultures in bioreactors or in transgenic plants.
CMViva system using transient production:
CMViva system using stably transformed cell cultures in bioreactors:
Both methods provide:
Country | Type | Number | Dated | Case |
United States Of America | Issued Patent | 10,421,973 | 09/24/2019 | 2006-640 |
Cucumber mosaic virus, viral amplicon, recombinant, proteins, recombinant proteins, protein expression system, CMViva, plant-based protein expression, bioreactor.